Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Stephan E BaldusHelmut E Gabbert

Abstract

Epidermal growth factor receptor (EGFR) antibody therapy is established in patients with wild-type KRAS colorectal carcinoma; however, up to 50% of these patients do not respond to this therapy. To identify the possible causes of this therapy failure, we searched for mutations in different EGFR-dependent signaling proteins and analyzed their distribution patterns in primary tumors and corresponding metastases. Tumor tissues, macrodissected from tumor centers, invasion fronts (n = 100), lymph nodes (n = 55), and distant metastases (n = 20), respectively, were subjected to DNA extraction and mutation analysis of KRAS, BRAF, and PIK3CA. Activating mutations were detected in 41% (KRAS), 7% (BRAF), and 21% (PIK3CA) of the primary tumors. By comparing tumor centers and invasion fronts, the intratumoral heterogeneity of KRAS, BRAF, and PIK3CA mutations was observed in 8%, 1%, and 5% of primary tumors, respectively. Heterogeneity between primary tumors and lymph node metastases was found in 31% (KRAS), 4% (BRAF), and 13% (PIK3CA) of the cases. Heterogeneity between primary tumors and distant metastases was present in two patients (10%) for KRAS and one patient for PIK3CA (5%), but not for BRAF. Discordant results between primary tumors...Continue Reading

Citations

May 17, 2011·International Journal of Colorectal Disease·Satu OltedalOddmund Nordgård
Mar 8, 2011·Clinical & Experimental Metastasis·Teodora Evgenieva GoranovaKikuya Kato
Sep 21, 2010·Pathology Oncology Research : POR·Apostolos ZaravinosDemetrios A Spandidos
Nov 12, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Dongwei Gao, Sha Li
Feb 23, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Apr 26, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Aude LamyJean-Christophe Sabourin
Sep 1, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alexandra VoutsinaVassilis Georgoulias
Mar 1, 2013·The New England Journal of Medicine·Samuel Aparicio, Carlos Caldas
Mar 8, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SantiniG Tonini
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D E AustG B Baretton
Jan 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D TougeronL Karayan-Tapon
Nov 16, 2013·Journal of the National Cancer Institute·Shuji OginoUNKNOWN Alliance for Clinical Trials in Oncology
Jul 8, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ingrid VandenputFrédéric Amant
Mar 24, 2011·The Cancer Journal·Rodrigo DienstmannJosep Tabernero
Jan 28, 2014·Biochemistry. Biokhimii︠a︡·T S GerashchenkoN V Cherdyntseva
Aug 9, 2012·Journal of Clinical Pathology·Umberto MalapelleGiancarlo Troncone
Jun 6, 2012·Chemotherapy Research and Practice·Linda MileshkinMichael Michael
Feb 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaoyun LiaoShuji Ogino
Nov 25, 2011·Future Oncology·Leticia De Mattos-ArrudaJosep Tabernero
Feb 23, 2011·International Journal of Molecular Sciences·Larissa BelovRichard I Christopherson
Mar 26, 2011·Pathology Research International·Kevin M Sullivan, Peter S Kozuch
Jan 10, 2013·International Journal of Clinical Oncology·Yuka KanekoMasakazu Yamamoto
Nov 5, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kaidi MikhitarianChanjuan Shi
Jun 3, 2014·Journal of Translational Medicine·Ming-Yii HuangShiu-Ru Lin
Oct 25, 2012·Annual Review of Pathology·Vanessa AlmendroKornelia Polyak
Jul 8, 2014·Human Pathology·Dov HershkovitzMichael Vieth
Nov 26, 2010·Annual Review of Pathology·Eric R Fearon
Nov 27, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ferga C GleesonMichael J Levy

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.